Michael Popelka

Title: Innovations of Michael Popelka in Corn Biotechnology

Introduction

Michael Popelka is an accomplished inventor based in Sioux Falls, South Dakota. He has made significant contributions to the field of corn biotechnology, holding three patents that focus on inbred corn lines. His work has implications for agricultural practices and crop production.

Latest Patents

One of his notable patents is for the inbred corn line designated CD9. This patent discloses the seeds of inbred corn line CD9, as well as the plants and plant parts derived from it. The patent outlines methods for producing corn plants, either inbred or hybrid, by crossing inbred corn line CD9 with itself or other corn lines. Additionally, it covers products produced from the seeds, plants, or parts of inbred corn line CD9, including transgenic plants that contain specific genetic material.

Another significant patent is for the inbred corn line designated MK2. Similar to CD9, this patent details the seeds, plants, and plant parts of inbred corn line MK2. It also describes methods for producing corn plants through crossing and the resulting products from these plants. The patent further includes methods for creating transgenic plants derived from inbred corn line MK2.

Career Highlights

Throughout his career, Michael Popelka has worked with prominent companies in the agricultural sector. He has been associated with Limagrain Europe S.A. and KWS Saat SE & Co. KGaA, where he has contributed to advancements in corn breeding and biotechnology.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Michael Popelka's innovations in corn biotechnology, particularly through his patents on inbred corn lines CD9 and MK2, demonstrate his commitment to enhancing agricultural productivity. His work continues to influence the field and supports advancements in crop science.